Trailhead Biosystems is a biotechnology company that focuses on using hardware and software services to develop cell therapy technology. Trailhead Biosystems works with companies that strive to innovate cell regeneration through advanced machinery methods.
“Trailhead robotically conducts the largest dimensioned experiments in biology, using machine learning to discover critical process parameters and combinatorial inputs that explain biological responses.” -Trailhead Biosystems
In recent news, Trailhead Biosystems is working with governmental programs in addition to foundations in order to combat Covid-19.
“We are developing a drug combination to treat COVID-19. We have identified a triple combination of existing drugs that has shown efficacy against SARS-CoV-2.” -Trailhead Biosystems.
As of November, Trailhead Biosystems raised $6.6 million in series A financing in order to fund their research for cell therapy to treat type I diabetes, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease and blood disorders.
